Drug-exercise interactions.
Lowenthal
D T
DT
Kendrick
Z V
ZV
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D045930:Anabolic Agents / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D004071:Digitalis Glycosides / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D009132:Muscles / Q000187:drug effects; D009566:Nitrates / Q000494:pharmacology; D005082:Physical Exertion; D012459:Salicylates / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D009566:Nitrates; D012459:Salicylates; D014665:Vasodilator Agents; D002110:Caffeine; D000431:Ethanol; D000661:Amphetamine